grade
synthesis grade
Quality Segment
vapor pressure
0.19 hPa ( 20 °C)
assay
≥98.0% (GC)
form
liquid
potency
2820 mg/kg LD50, oral (Rat)
pH
1.2 (20 °C, 129 g/L in H2O)
bp
192 °C/1013 hPa (decomposes)
mp
-4 °C
density
1.57 g/cm3 at 20 °C
storage temp.
2-30°C
SMILES string
ClC(Cl)C(=O)O
InChI
1S/C2H2Cl2O2/c3-1(4)2(5)6/h1H,(H,5,6)
InChI key
JXTHNDFMNIQAHM-UHFFFAOYSA-N
Application
- Controlled drug release systems: Research includes the application of Dichloroacetic acid in the synthesis of sulfonated polyether ketone membranes that are embedded with nalidixic acid, highlighting its utility in developing emerging controlled drug releasers in medical applications (Padinjarathil et al., 2023).
Analysis Note
Assay (GC, area%): ≥ 98.0 % (a/a)
Density (d 20 °C/ 4 °C): 1.560 - 1.570
Identity (IR): passes test
Due to its specific melting range the product may be solid, liquid, a solidified melt or a supercooled melt.
Density (d 20 °C/ 4 °C): 1.560 - 1.570
Identity (IR): passes test
Due to its specific melting range the product may be solid, liquid, a solidified melt or a supercooled melt.
Other Notes
Replaces: DX0653
Still not finding the right product?
Explore all of our products under Dichloroacetic acid
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Aquatic Acute 1 - Aquatic Chronic 3 - Carc. 2 - Eye Dam. 1 - Lact. - Met. Corr. 1 - Repr. 1B - Skin Corr. 1 - STOT RE 2 Oral - STOT SE 3
target_organs
Brain,Liver,Testes, Respiratory system
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
flash_point_f
235.4 °F - closed cup
flash_point_c
113 °C - closed cup



